- Details
- Description
Mounjaro 12.5 mg KwikPen is a prescription, once-weekly injectable medicine containing tirzepatide, a GIP and GLP-1 receptor agonist. It is used to help improve blood-glucose control in adults with type 2 diabetes and, where approved, to support weight management alongside diet and physical activity. Each dose contains 12.5 mg of tirzepatide in 0.6 mL, and one multi-dose KwikPen provides 4 weekly doses, containing 50 mg of tirzepatide in 2.4 mL total.
Active substance: Tirzepatide
Strength: 12.5 mg/0.6 mL per dose
Dosage form: Solution for subcutaneous injection
Pack: 1 multi-dose pre-filled KwikPen containing 4 doses.
Pack contents: Each 12.5 mg KwikPen contains 50 mg of tirzepatide in 2.4 mL and provides 4 doses of 12.5 mg. Needles are not included.
Manufacturer: The UK product information lists Eli Lilly Italia (Italy), Lilly S.A. (Spain), Lilly France (France), and Millmount Healthcare Limited (Ireland) as manufacturers. The exact origin should be checked on the specific package/batch
